Business / Finance

RSS

Aon second quarter total revenue increases 48% to $2.8 billion

Aon Corporation today reported results for the second quarter ended June 30, 2011.

29 Jul 2011

Magellan reports second quarter net revenue of $698.3 million

Magellan Health Services Inc. today reported financial results for the second quarter of 2011, as summarized below. For the quarter ended June 30, 2011, the company reported net revenue of $698.3 million, segment profit of $75.9 million, and net income of $34.2 million or $1.07 per diluted common share.

29 Jul 2011

Coventry Health Care second quarter operating revenues increase 6% to $3.0 billion

Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended June 30, 2011.

29 Jul 2011

Roka Bioscience raises $20M in Series C equity financing

Roka Bioscience, Inc. announced today that it recently completed a Series C round of equity financing, raising $20 million in new capital.

29 Jul 2011

AccuVein announces $22.5M Series B financing

AccuVein Inc., a global leader in medical imaging technology and the creator of the AV300, the world's first hand-held, non-contact vein illumination device, announced today that it has secured $22.5 million in a Series B financing.

29 Jul 2011

Curis second quarter net loss increases to $4.9 million

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.

28 Jul 2011

Celgene reports second quarter total revenue of $1.18 billion

Celgene Corporation announced non-GAAP net income of $417 million, or non-GAAP diluted earnings per share of $0.89, for the quarter ended June 30, 2011. Non-GAAP net income for the second quarter of 2010 was $323 million, or non-GAAP diluted earnings per share of $0.69.

28 Jul 2011

NeuroMetrix second quarter total revenues decrease to $2.6 million

NeuroMetrix, Inc., a science-based health care company improving patient care through neurotechnology, today reported business and financial highlights for the quarter and six months ended June 30, 2011.

28 Jul 2011

Solazyme launches anti-aging skincare line, Algenist at Space NK stores

Solazyme, Inc., a renewable oil and bioproducts company, has signed a distribution agreement with the United Kingdom's most innovative beauty retailer, Space NK, to expand the sales network of the company's luxury skincare line, Algenist, to include all 60 Space NK stores throughout the country.

28 Jul 2011

Five Star Quality Care second quarter total revenues increase 3.4% to $312.6 million

Five Star Quality Care, Inc. today announced its financial results for the quarter and six months ended June 30, 2011.

28 Jul 2011

Natus Medical second quarter revenue increases 10% to $58.1 million

Natus Medical Incorporated today announced financial results for the three and six months ended June 30, 2011.

28 Jul 2011

POZEN reports revenue of $4.6 million for second quarter 2011

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2011.

28 Jul 2011

TRTB announces supplier contract with Nada Marketing

True 2 Beauty, Inc., a leading distributor of male & female lifestyle ingestible products and health & beauty accessories in the United States, is pleased to announce an exclusive supplier contract between TRTB and Nada Marketing, Inc.

28 Jul 2011

Quality Systems first quarter net revenues increase 21% to $100.4 million

Quality Systems, Inc. announced today results for its fiscal 2012 first quarter ended June 30, 2011.

28 Jul 2011

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business

FUJIFILM Corporation President and CEO, Shigetaka Komori and Dr. Reddy's Laboratories Ltd. Vice-Chairman and CEO, G V Prasad today signed a Memorandum of Understanding to enter into an exclusive partnership in the generic drugs business for the Japanese market and to establish a joint venture in Japan.

28 Jul 2011

Biosign closes brokered private placement for $1,900,000

Biosign Technologies Inc. announced today the closing of a brokered private placement of units of the Company for gross proceeds of approximately $1,900,000.

28 Jul 2011

Watson to acquire portfolio of divested generic pharmaceutical products

Watson Pharmaceuticals, Inc. today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Company and Paddock Laboratories.

28 Jul 2011

BioSante to offer and sell shares of common stock in an underwritten public offering

BioSante Pharmaceuticals, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by BioSante.

28 Jul 2011

BD to acquire Carmel Pharma

BD, a leading global medical technology company, announced today that it signed a definitive agreement to acquire Carmel Pharma, Inc., a Swedish company that manufactures the PhaSeal System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.

From BD (Becton, Dickinson and Company) 28 Jul 2011